Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Cencora (COR)

NYSE Health Care Health Care Distributors S&P 500
$333.56
-6.12 (-1.80%)
Close of Nov 06, 2026 · end-of-day data
Source: Cencora's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$146.85B$153.14B$167.94B$179.59B$189.89B$213.99B$238.59B$262.17B$293.96B$321.33B
Cost of revenue$142.58B$148.60B$163.33B$174.45B$184.70B$207.05B$230.29B$253.21B$284.05B$309.85B
Gross profit$4.27B$4.55B$4.61B$5.14B$5.19B$6.94B$8.30B$8.96B$9.91B$11.48B
Selling, general & admin$2.09B$2.13B$2.46B$2.66B$2.77B$3.59B$4.85B$5.31B$5.66B$6.49B
Operating income$1.53B$1.06B$1.44B$1.11B-$5.14B$2.35B$2.37B$2.34B$2.18B$2.63B
Pre-tax income$1.39B$917.89M$1.18B$967.11M-$5.29B$2.22B$2.18B$2.16B$2.00B$2.26B
Income tax-$37.02M$553.40M-$438.47M$112.97M-$1.89B$677.25M$516.52M$428.26M$484.70M$690.52M
Net income$1.43B$364.48M$1.66B$855.37M-$3.41B$1.54B$1.70B$1.75B$1.51B$1.55B
EBITDA$1.89B$1.46B$1.91B$1.57B-$4.74B$2.86B$3.06B$3.30B$3.27B$3.68B
EPS (basic)$6.73$1.67$7.61$4.07$-16.65$7.48$8.15$8.62$7.60$8.02
EPS (diluted)$6.32$1.64$7.53$4.04$-16.65$7.39$8.04$8.53$7.53$7.96
Diluted shares225.96M221.60M220.34M211.84M204.78M208.47M211.21M204.59M200.28M195.21M
Gross margin2.9%3.0%2.7%2.9%2.7%3.2%3.5%3.4%3.4%3.6%
Operating margin1.0%0.7%0.9%0.6%-2.7%1.1%1.0%0.9%0.7%0.8%
Net margin1.0%0.2%1.0%0.5%-1.8%0.7%0.7%0.7%0.5%0.5%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$2.74B$2.44B$2.49B$3.37B$4.60B$2.55B$3.39B$2.59B$3.13B$4.36B
Receivables$9.18B$10.30B$11.31B$12.39B$13.85B$18.17B$18.45B$20.91B$23.87B$25.23B
Inventory$10.72B$11.46B$11.92B$11.06B$12.59B$15.37B$15.56B$17.45B$19.00B$20.49B
Total current assets$22.85B$24.30B$25.89B$28.13B$33.06B$38.80B$39.59B$42.80B$47.72B$52.24B
Goodwill$5.99B$6.04B$6.66B$6.71B$6.71B$9.03B$8.50B$9.57B$9.32B$13.68B
Total assets$33.64B$35.32B$37.67B$39.17B$44.27B$57.34B$56.56B$62.56B$67.10B$76.59B
Total current liabilities$25.28B$26.82B$27.87B$29.58B$33.85B$41.36B$43.48B$48.83B$54.28B$57.82B
Short-term debt$610.21M$12.12M$151.66M$139.01M$501.26M$300.21M$1.07B$641.34M$576.33M$117.78M
Long-term debt$3.58B$3.43B$4.16B$4.03B$3.62B$6.38B$4.63B$4.15B$3.81B$7.54B
Total debt$4.19B$3.44B$4.31B$4.17B$4.12B$6.68B$5.70B$4.79B$4.39B$7.66B
Total liabilities$31.51B$33.25B$34.74B$36.29B$45.29B$57.11B$56.77B$62.04B$66.46B$75.08B
Shareholders' equity$2.13B$2.06B$2.93B$2.88B-$1.02B$223.35M-$211.56M$522.00M$645.94M$1.51B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$3.18B$1.50B$1.41B$2.34B$2.21B$2.67B$2.70B$3.91B$3.48B$3.88B
Capital expenditures$464.62M$466.40M$336.41M$310.22M$369.68M$438.22M$496.32M$458.36M$487.17M$667.98M
Free cash flow$2.71B$1.04B$1.07B$2.03B$1.84B$2.23B$2.21B$3.45B$3.00B$3.21B
Investing cash flow-$3.17B-$498.04M-$1.11B-$375.83M-$379.87M-$6.14B-$368.44M-$2.60B-$618.10M-$4.98B
Financing cash flow$565.07M-$1.31B-$242.87M-$1.09B-$603.62M$1.95B-$1.75B-$2.22B-$2.33B$2.25B
Dividends paid$288.48M$320.27M$333.04M$338.97M$343.58M$366.65M$391.69M$398.75M$416.17M$437.08M
Share buybacks$2.27B$329.93M$639.24M$674.03M$420.45M$82.15M$483.70M$1.18B$1.49B$435.47M
Stock-based compensation$64.99M$62.21M$62.32M$58.87M$74.41M$99.59M$93.40M$124.62M$148.00M$147.96M
Depreciation & amortization$364.74M$397.60M$465.13M$462.41M$391.06M$505.17M$693.89M$963.90M$1.09B$1.05B

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.